Literature DB >> 28225421

Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions.

.   

Abstract

Carrier screening is a term used to describe genetic testing that is performed on an individual who does not have any overt phenotype for a genetic disorder but may have one variant allele within a gene(s) associated with a diagnosis. Information about carrier screening should be provided to every pregnant woman. Carrier screening and counseling ideally should be performed before pregnancy because this enables couples to learn about their reproductive risk and consider the most complete range of reproductive options. A patient may decline any or all screening. When an individual is found to be a carrier for a genetic condition, his or her relatives are at risk of carrying the same mutation. The patient should be encouraged to inform his or her relatives of the risk and the availability of carrier screening. If an individual is found to be a carrier for a specific condition, the patient's reproductive partner should be offered testing in order to receive informed genetic counseling about potential reproductive outcomes. If both partners are found to be carriers of a genetic condition, genetic counseling should be offered. What follows is a detailed discussion of some of the more common genetic conditions for which carrier screening is recommended in at least some segments of the population.

Entities:  

Mesh:

Year:  2017        PMID: 28225421     DOI: 10.1097/AOG.0000000000001948

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Expanded carrier screening: a current survey of physician utilization and attitudes.

Authors:  Allison Briggs; Parvaneh K Nouri; Michael Galloway; Kathleen O'Leary; Nigel Pereira; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2018-08-01       Impact factor: 3.412

2.  Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.

Authors:  Lin Zheng; Hailong Huang; Xiaoqing Wu; Qingmei Shen; Meihuan Chen; Meiying Wang; Linjuan Su; Liangpu Xu
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-27       Impact factor: 0.900

Review 3.  Obstetric management, tests, and technologies that impact childhood development.

Authors:  Christopher M Novak; Ernest M Graham
Journal:  Dev Med Child Neurol       Date:  2019-01-28       Impact factor: 5.449

4.  Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder.

Authors:  Elizabeth A Normand; Alicia Braxton; Salma Nassef; Patricia A Ward; Francesco Vetrini; Weimin He; Vipulkumar Patel; Chunjing Qu; Lauren E Westerfield; Samantha Stover; Avinash V Dharmadhikari; Donna M Muzny; Richard A Gibbs; Hongzheng Dai; Linyan Meng; Xia Wang; Rui Xiao; Pengfei Liu; Weimin Bi; Fan Xia; Magdalena Walkiewicz; Ignatia B Van den Veyver; Christine M Eng; Yaping Yang
Journal:  Genome Med       Date:  2018-09-28       Impact factor: 11.117

5.  Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen.

Authors:  Kyle A Beauchamp; Katherine A Johansen Taber; Dale Muzzey
Journal:  Genet Med       Date:  2019-02-14       Impact factor: 8.822

6.  The ethics of preconception expanded carrier screening in patients seeking assisted reproduction.

Authors:  Guido de Wert; Sanne van der Hout; Mariëtte Goddijn; Rita Vassena; Lucy Frith; Nathalie Vermeulen; Ursula Eichenlaub-Ritter
Journal:  Hum Reprod Open       Date:  2021-02-12

7.  Interest in Cancer Predisposition Testing and Carrier Screening Offered as Part of Routine Healthcare Among an Ethnically Diverse Sample of Young Women.

Authors:  Kimberly A Kaphingst; Jemar R Bather; Brianne M Daly; Daniel Chavez-Yenter; Alexis Vega; Wendy K Kohlmann
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

8.  Multisite Evaluation and Validation of a Sensitive Diagnostic and Screening System for Spinal Muscular Atrophy that Reports SMN1 and SMN2 Copy Number, along with Disease Modifier and Gene Duplication Variants.

Authors:  John N Milligan; Jessica L Larson; Stela Filipovic-Sadic; Walairat Laosinchai-Wolf; Ya-Wen Huang; Tsang-Ming Ko; Kristin M Abbott; Henny H Lemmink; Minna Toivonen; Johanna Schleutker; Caren Gentile; Vivianna M Van Deerlin; Huiping Zhu; Gary J Latham
Journal:  J Mol Diagn       Date:  2021-03-30       Impact factor: 5.341

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.